跳至主要内容
临床试验/NCT00883454
NCT00883454已完成不适用

Estimation of Functional Liver Reserve in Patients With Hepatocellular Carcinoma in Cirrhosis: the Value of Preoperative Cholinesterases

University of Milan1 个研究点 分布在 1 个国家目标入组 181 人开始时间: 2009年4月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
181
试验地点
1
主要终点
The primary outcome was to investigate the value of preoperative cholinesterases in predict postoperative adverse outcome after hepatic resection for hepatocellular carcinoma in cirrhosis.

研究概览

简要总结

Estimation of functional liver reserve in patients with hepatocellular carcinoma (HCC) in cirrhosis is of paramount importance to properly select candidates for surgical resection. Together with the value of bilirubin, the presence/absence of ascites and esophageal varices, and the rate of residual liver volume, which are our current parameters to measure functional liver reserve, the investigators sought to investigate the value of preoperative cholinesterases (CHE) in predict postoperative adverse outcome after hepatic resection for HCC.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Total bilirubin < 2 mg/dl
  • No esophageal varices, or esophageal varices eradicated by endoscopy
  • Liver volume:
  • residual liver volume > or = 40% if total bilirubin < 1 mg/dl
  • residual liver volume > or = 50% if total bilirubin between 1 and 1.5 mg/dl
  • only limited resection if total bilirubin > 1.5 mg/dl
  • Portal vein embolization was selected in any case in whom RLV did not fit the previous requirements.

排除标准

  • Total bilirubin > 2 mg/dl
  • Refractory ascites
  • Esophageal varices

结局指标

主要结局

The primary outcome was to investigate the value of preoperative cholinesterases in predict postoperative adverse outcome after hepatic resection for hepatocellular carcinoma in cirrhosis.

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验